New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis
Franco Frati,1 Lorenzo Cecchi,2,3 Enrico Scala,4 Erminia Ridolo,5 Ilaria Dell'Albani,1 Eleni Makrì,6 Giovanni Pajno,7 Cristoforo Incorvaia6 1Medical and Scientific Department, Stallergenes, Milan, Italy; 2Interdepartmental Centre of Bioclimatology, University of Florence, Florenc...
Enregistré dans:
Auteurs principaux: | Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno G, Incorvaia C |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ac21c935e5bc48b2a71bbabcfaa02d42 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
par: Frati F, et autres
Publié: (2015) -
Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
par: Wang Jiarong, et autres
Publié: (2021) -
Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
par: Galateja Jordakieva, et autres
Publié: (2017) -
Preference for Immunotherapy with Tablets by People with Allergic Rhinitis
par: Tankersley M, et autres
Publié: (2021) -
Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
par: Anne K. Ellis, et autres
Publié: (2021)